Cowden Syndrome 2 Cn293886
Cowden syndrome 2 is a related genetic condition causing benign tumors and elevated cancer risk. It requires regular medical surveillance and screening. Genetic counseling is often recommended for families.
Key facts at a glance
- ICD-10
- C96.9
- ICD-11
- 2A00.0
- Body system
- oncologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Breast lump
(reproductive)Generalized symptoms
(oncologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Cutaneous papillomas
(integumentary)Colon polyps
(gastrointestinal)Thyroid goiter
(endocrine)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Enhanced Tumor Surveillance Protocol
Regular imaging and laboratory screening for thyroid, breast, endometrial, renal, and colonic neoplasms using evidence-based interval schedules.
Polypectomy and Lesion Removal
Endoscopic or surgical removal of benign hamartomatous polyps and mucocutaneous lesions that may cause symptoms or undergo malignant transformation.
Additional treatment options
Cancer-Prevention Nutrition
Anti-inflammatory diet rich in fruits, vegetables, and fiber with reduced processed foods to potentially decrease tumor development risk.
dietaryIntegrative Symptom Management
Complementary approaches including acupuncture or herbal support under specialist supervision for managing treatment-related symptoms.
complementaryFamily-Based Counseling
Psychological interventions involving the whole family to address anxiety, support treatment adherence, and facilitate communication about genetic risks.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Cowden Syndrome 2 Cn293886?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Pilarski R, Burt R, Kohlman W, Pho L, Shannon KM, Swisher E. Cowden Syndrome and the PTEN Hamartoma Tumor Syndrome: Systematic Review and Revised Diagnostic Criteria. J Natl Compr Canc Netw. 2013;11(11):1323-1332.
Tan MH, Mester JL, Ngeow J, Rybicki LA, Orloff MS, Eng C. Lifetime Cancer Risk in Individuals with Germline PTEN Mutations. Clin Cancer Res. 2012;18(2):421-428.
Henderson CJ, Ngeow J, Collins JA, et al. Increased Cancer Incidence in the PTEN Hamartoma Tumor Syndrome. J Clin Endocrinol Metab. 2020;105(4):1027-1034.
Bubien V, Bonnet F, Brouste V, et al. High Cumulative Risks of Cancer in Individuals with PTEN Mutations. J Med Genet. 2013;50(4):255-263.
Medication Comparisons
Compare medications used to treat Cowden Syndrome 2 Cn293886. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy